Reflux and aspiration in the intensive care unit

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Critical illness often involves multisystem organ dysfunction and/or failure. Therapeutic interventions aimed at one source of illness may have undesired consequences elsewhere. Gastroesophageal reflux is common in critically ill patients, and is promoted or further exacerbated by the initiation of mechanical ventilation necessitated by respiratory failure. Prophylaxis against stress ulcers of the gastrointestinal mucosa may promote bacterial overgrowth and perhaps ventilator-associated pneumonia (VAP) by eliminating protective gastric acidity. Identification of which subgroups of critically ill patients should receive stress-ulcer prophylaxis, and which pharmacological agents should be used for this purpose, are areas of ongoing investigation. Provision of enteral nutrition is an essential therapeutic intervention for critically ill patients; however, risk of aspiration of oropharyngeal and gastric contents is increased by the administration of feeds to the gastrointestinal tract. Delivery of enteral feeds beyond the gastric pylorus directly into the small intestine has been supported as a strategy to decrease the incidence of aspiration and to optimize the amount of nutrition delivered to the patient, however supportive data are not robust and debate continues. The severe consequences of VAP have stimulated the development of multi-component patient care “bundles” (including head-of-bed elevation and oral care with chlorhexidine) that have shown some success in decreasing occurrence of VAP and other unwanted iatrogenic consequences in the intensive care unit (ICU), but outcomes to date have been mixed, and individual components of the bundle have shown discordant effects on patientcentered outcomes.

Original languageEnglish (US)
Title of host publicationReflux Aspiration and Lung Disease
PublisherSpringer International Publishing
Pages227-233
Number of pages7
ISBN (Electronic)9783319905259
ISBN (Print)9783319905235
DOIs
StatePublished - Jan 1 2018

Fingerprint

Critical Illness
Ventilator-Associated Pneumonia
Intensive Care Units
Small Intestine
Ulcer
Patient Care Bundles
Stomach
Gastrointestinal Contents
Chlorhexidine
Pylorus
Enteral Nutrition
Gastroesophageal Reflux
Artificial Respiration
Respiratory Insufficiency
Gastrointestinal Tract
Mucous Membrane
Head
Pharmacology
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Dicpinigaitis, P. V. (2018). Reflux and aspiration in the intensive care unit. In Reflux Aspiration and Lung Disease (pp. 227-233). Springer International Publishing. https://doi.org/10.1007/978-3-319-90525-9_19

Reflux and aspiration in the intensive care unit. / Dicpinigaitis, Peter Vytautas.

Reflux Aspiration and Lung Disease. Springer International Publishing, 2018. p. 227-233.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dicpinigaitis, PV 2018, Reflux and aspiration in the intensive care unit. in Reflux Aspiration and Lung Disease. Springer International Publishing, pp. 227-233. https://doi.org/10.1007/978-3-319-90525-9_19
Dicpinigaitis PV. Reflux and aspiration in the intensive care unit. In Reflux Aspiration and Lung Disease. Springer International Publishing. 2018. p. 227-233 https://doi.org/10.1007/978-3-319-90525-9_19
Dicpinigaitis, Peter Vytautas. / Reflux and aspiration in the intensive care unit. Reflux Aspiration and Lung Disease. Springer International Publishing, 2018. pp. 227-233
@inbook{9969342ee00547fbb5c2cf4f3d4b08cc,
title = "Reflux and aspiration in the intensive care unit",
abstract = "Critical illness often involves multisystem organ dysfunction and/or failure. Therapeutic interventions aimed at one source of illness may have undesired consequences elsewhere. Gastroesophageal reflux is common in critically ill patients, and is promoted or further exacerbated by the initiation of mechanical ventilation necessitated by respiratory failure. Prophylaxis against stress ulcers of the gastrointestinal mucosa may promote bacterial overgrowth and perhaps ventilator-associated pneumonia (VAP) by eliminating protective gastric acidity. Identification of which subgroups of critically ill patients should receive stress-ulcer prophylaxis, and which pharmacological agents should be used for this purpose, are areas of ongoing investigation. Provision of enteral nutrition is an essential therapeutic intervention for critically ill patients; however, risk of aspiration of oropharyngeal and gastric contents is increased by the administration of feeds to the gastrointestinal tract. Delivery of enteral feeds beyond the gastric pylorus directly into the small intestine has been supported as a strategy to decrease the incidence of aspiration and to optimize the amount of nutrition delivered to the patient, however supportive data are not robust and debate continues. The severe consequences of VAP have stimulated the development of multi-component patient care “bundles” (including head-of-bed elevation and oral care with chlorhexidine) that have shown some success in decreasing occurrence of VAP and other unwanted iatrogenic consequences in the intensive care unit (ICU), but outcomes to date have been mixed, and individual components of the bundle have shown discordant effects on patientcentered outcomes.",
author = "Dicpinigaitis, {Peter Vytautas}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-90525-9_19",
language = "English (US)",
isbn = "9783319905235",
pages = "227--233",
booktitle = "Reflux Aspiration and Lung Disease",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Reflux and aspiration in the intensive care unit

AU - Dicpinigaitis, Peter Vytautas

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Critical illness often involves multisystem organ dysfunction and/or failure. Therapeutic interventions aimed at one source of illness may have undesired consequences elsewhere. Gastroesophageal reflux is common in critically ill patients, and is promoted or further exacerbated by the initiation of mechanical ventilation necessitated by respiratory failure. Prophylaxis against stress ulcers of the gastrointestinal mucosa may promote bacterial overgrowth and perhaps ventilator-associated pneumonia (VAP) by eliminating protective gastric acidity. Identification of which subgroups of critically ill patients should receive stress-ulcer prophylaxis, and which pharmacological agents should be used for this purpose, are areas of ongoing investigation. Provision of enteral nutrition is an essential therapeutic intervention for critically ill patients; however, risk of aspiration of oropharyngeal and gastric contents is increased by the administration of feeds to the gastrointestinal tract. Delivery of enteral feeds beyond the gastric pylorus directly into the small intestine has been supported as a strategy to decrease the incidence of aspiration and to optimize the amount of nutrition delivered to the patient, however supportive data are not robust and debate continues. The severe consequences of VAP have stimulated the development of multi-component patient care “bundles” (including head-of-bed elevation and oral care with chlorhexidine) that have shown some success in decreasing occurrence of VAP and other unwanted iatrogenic consequences in the intensive care unit (ICU), but outcomes to date have been mixed, and individual components of the bundle have shown discordant effects on patientcentered outcomes.

AB - Critical illness often involves multisystem organ dysfunction and/or failure. Therapeutic interventions aimed at one source of illness may have undesired consequences elsewhere. Gastroesophageal reflux is common in critically ill patients, and is promoted or further exacerbated by the initiation of mechanical ventilation necessitated by respiratory failure. Prophylaxis against stress ulcers of the gastrointestinal mucosa may promote bacterial overgrowth and perhaps ventilator-associated pneumonia (VAP) by eliminating protective gastric acidity. Identification of which subgroups of critically ill patients should receive stress-ulcer prophylaxis, and which pharmacological agents should be used for this purpose, are areas of ongoing investigation. Provision of enteral nutrition is an essential therapeutic intervention for critically ill patients; however, risk of aspiration of oropharyngeal and gastric contents is increased by the administration of feeds to the gastrointestinal tract. Delivery of enteral feeds beyond the gastric pylorus directly into the small intestine has been supported as a strategy to decrease the incidence of aspiration and to optimize the amount of nutrition delivered to the patient, however supportive data are not robust and debate continues. The severe consequences of VAP have stimulated the development of multi-component patient care “bundles” (including head-of-bed elevation and oral care with chlorhexidine) that have shown some success in decreasing occurrence of VAP and other unwanted iatrogenic consequences in the intensive care unit (ICU), but outcomes to date have been mixed, and individual components of the bundle have shown discordant effects on patientcentered outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85064357769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064357769&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-90525-9_19

DO - 10.1007/978-3-319-90525-9_19

M3 - Chapter

AN - SCOPUS:85064357769

SN - 9783319905235

SP - 227

EP - 233

BT - Reflux Aspiration and Lung Disease

PB - Springer International Publishing

ER -